Cargando…
Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study
BACKGROUND: Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19). In this retrospective study, we assessed the clinical effects of HCQ/AZI, with a 28-days follow-up. METHODS: In a registry-study which included patients hospitaliz...
Autores principales: | Saib, Anis, Amara, Walid, Wang, Pascal, Cattan, Simon, Dellal, Azeddine, Regaieg, Kais, Nahon, Stephane, Nallet, Olivier, Nguyen, Lee S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189518/ https://www.ncbi.nlm.nih.gov/pubmed/34106964 http://dx.doi.org/10.1371/journal.pone.0252388 |
Ejemplares similares
-
Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022) -
Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021) -
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021) -
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022) -
Azithromycin/eculizumab/hydroxychloroquine: Normocytic anaemia, lack of efficacy and off-label use: case report
Publicado: (2022)